A categorical description of the company or organization based on its primary business
objective - Biopharma (Large-Cap, Mid-Cap, Small-Cap and Private); Medical Devices
and Diagnostics; Tools, Services, and Manufacturing; Non-Profit or Major Disease
Foundation; Academic; Government; Pricing and Regulatory Body; Financial; and Other
Large-Cap Biopharma (≥$50 billion)
Mid-Cap Biopharma ($1-$50 billion)
Small-Cap Biopharma (<$1 billion)
Biopharma companies are defined as those primarily engaged in researching, discovering,
developing, and commercializing technologies and pharmaceutical drugs used in human
medical therapies. This includes branded, generic, prescription, and over-the-counter
(OTC) drug products. This also includes companies developing technology platforms
that are used for drug discovery, chemical library screening, development/optimization,
and formulation. Biopharma companies are then characterized by their market capitalization
in three tiers, or as Private Biopharma. Reviews of market cap designations are
conducted on a quarterly basis, and reviews of private/public status are conducted
as needed for IPOs or other ownership events.
Medical Devices and Diagnostics
Medical Devices and Diagnostics companies are primarily engaged in developing, manufacturing,
and commercializing devices such as those used for medical therapy, drug delivery,
and monitoring. This category also includes companies primarily engaged in developing,
manufacturing, and commercializing diagnostic tests and biomarkers for use in human
therapies. This category does not include companies developing assays, reagents,
and systems used primarily in laboratory research, or companies developing large-scale
instrumentation systems (see Tools, Services, and Manufacturing).
Tools, Services, and Manufacturing
Tools, Services, and Manufacturing includes companies primarily engaged in lab reagents,
tools and supplies used in pharmaceutical research (including software for bioinformatics,
genomics and proteomics), contract research organizations (CRO), contract manufacturing
organizations (CMO) and contract sales organizations (CSO). This category does not
include industrial and biotechnology chemical manufacturers (see Other).
Non-Profit or Major Disease Foundation
Non-Profit or Major Disease Foundations includes organizations that are engaged
in funding and advising R&D and/or raising the awareness for certain diseases (e.g.,
Cystic Fibrosis Foundation).
Academic organizations include university and institutional technology transfer
offices, and teaching and research hospitals.
Government organizations include government-funded research departments and stockpiling
organizations, and regional biopharma investment groups (e.g., NIH, U.S. Department
Pricing and Regulatory Body
Pricing and Regulatory Bodies includes groups and organizations that govern policies
on drug pricing, regulation, and reimbursement (e.g., German Federal Joint Committee
(G-BA), EC, NICE, FDA, EMA).
Financial organizations include venture capital and private equity firms, corporate
venture groups of biopharma companies, royalty buyout firms, and acquisition holding
companies (e.g., DRI Capital, Royalty Pharma, Deerfield Management).
This category includes consulting and software companies (other than bioinformatics
software), special consortia, and companies primarily engaged in chemical manufacturing
not specific to human pharmaceuticals. This category also includes companies primarily
developing and commercializing veterinary medicines, nutraceuticals, agricultural
products, packaging, and industrial / environmental biotechnology chemicals (e.g.,
Oracle, 3M Co., Kimberly-Clark Corp.).
FULL ACCESS TO BIOCENTURY ONLINE INTELLIGENCE (BCIQ) AND THE BIOCENTURY ARCHIVES IS LIMITED TO AUTHORIZED SUBSCRIBERS WHO HAVE READ AND AGREED TO THE BIOCENTURY USER AGREEMENT
. All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may not be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; and The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma’s Knowledge Center™ are trademarks of BioCentury Publications, Inc., P.O. Box 1246 San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.